查詢結果分析
相關文獻
- B型肝炎疫苗效價試驗用標準品之製備
- Control of Hepatitis B Virus Infection by Vaccination: The Taiwan Experience
- The Relationship between the Cold Chain System and Vaccine Potency in Taiwan: (Ⅰ) Live Measles Vaccine and MMR Vaccine
- The Relationship between the Cold Chain System and Vaccine Potency in Taiwan(Ⅱ)--Oral Polio Vaccine
- 民國七十五至八十八年市售藥用酵素製劑之品質調查
- Antimicrobial Resistance and Serotype Distribution of Streptococcus Pneumoniae Strains in Central Taiwan
- 市售輸入第八凝血因子及第九凝血因子製劑之效價試驗調查
- AIDS、省府虛級化、與B型肝炎疫苗--科學知識在臺灣的一種社會建構歷程
- 談血液透析患者應如何接種B型肝炎疫苗
- 國泰金融控股公司合併世華銀行之個案分析
頁籤選單縮合
| 題 名 | B型肝炎疫苗效價試驗用標準品之製備 |
|---|---|
| 作 者 | 林嘉伯; | 書刊名 | 藥物食品分析 |
| 卷 期 | 1:1 1993.01[民82.01] |
| 頁 次 | 頁43-48 |
| 分類號 | 418.293 |
| 關鍵詞 | B型肝炎疫苗; 效價; Hepatitis B vaccine; Reference standard; Potency test; |
| 語 文 | 中文(Chinese) |
| 英文摘要 | A well qualified plasma derived hepatitis B vaccine, coded 028A, was evaluated in the National Laboratories of Foods and Drugs for its potency to serve as the first national reference standard for hepatitis B vaccine for use in immunogenicity assays. This proposed national reference standard was assayed against the WHO plasma-derived hepatitis B reference standard, lot 96932. The relative potencies of lot 028A plasma-derived hepatitis B vaccine versus WHO lot 96932 vaccine was evaluated in a series of immunization studies for both guinea pig and Balb/c mouse groups by the parallel line assay method.Results obtained indicated that the relative potencies for the guinea pig and mouse groups were 1.04 ± 0.12 and 1.09 ± 0.39, respectively. This reference standard is intended for use in assays of hepatitis B vaccines in both mouse or guinea pig immunogenicity studies for the vaccine sealing tests in Taiwan. |
本系統中英文摘要資訊取自各篇刊載內容。